ВЛИЯНИЕ ДЕПРЕССИИ И ТРЕВОЖНОСТИ НА КАЧЕСТВО ЖИЗНИ ЛИЦ С ВЫСОКИМ КАРДИОВАСКУЛЯРНЫМ РИСКОМ

В статье проанализированы литературные источники, посвященные изучению коморбидности болезней системы кровообращения и тревожно-депрессивных расстройств, а также их влиянию на изменение качества жизни пациентов. Согласно литературным данным в большинстве исследований ключевыми инструментами оценки тревожности и депрессии являются шкалы GAD-7 и HADS, Бека, опросник Спилбергера, PHQ9 и Patient Health Questionnaire. В оценке качества жизни, связанного со здоровьем больных с высоким кардиоваскулярным риском, преимущественно используется неспецифический опросник SF-36. Высокая медико-социальная значимость повышения качества жизни пациентов, страдающих кардиоваскулярной патологией диктует необходимость изучения методов мониторинга коморбидных состояний и последующей разработки эффективных профилактических мероприятий.

болезни системы кровообращения, кардиоваскулярный риск, депрессия, тревожность, качество жизни, қан айналымы жүйесінің аурулары, крдиоваскулярлық қауіп, мазасыздану, өмір сүру сапасы

1. Аналитический материал расширенной коллегии министерства здравоохранения Республики Казахстан //rcrz.kz URL: http:// www.rcrz.kz/docs/broshura.pdf (дата обращения: 24.10.2018).

2. Грищенко С. В. Экологические факторы риска болезней системы кровообращения среди населения высокоурбанизированного региона //Вестник гигиены и эпидемиологии. -2017. - Т. 21, №3. - С. 227-232.

3. Ильина Т. Н. Медико-социологическое объяснение феномена качества жизни /Т. Н. Ильина, И. Л. Кром, И. Ю. Новичкова //Известия Саратовского университета. Сер. Социология. Политология.- 2011.- Т. 11,№4.- C. 20-26.

4. Каскаева Д. С. Оптимизация лечения больных артериальной гипертонией высокого сердечно-сосудистого риска в амбулаторно-поликлинических условиях: Автореф. дис..канд. мед. наук. - Красноярск, 2009. - 133 с.

5. Нуралиева Н. Ф. Депрессия и сердечно-сосудистые заболевания /Н. Ф. Нуралиева, Д. А. Напалков //Вестн. Рос. академии медицинских наук.- 2014.- Т. 69, №9-10.- С. 21-26.

6. Чешик И. А. Эпидемиология наиболее распространенных факторов риска, влияющих на развитие болезней системы кровообращения, и их вклад в смертность мужского населения трудоспособного возраста /И. А. Чешик, Т. М. Шаршакова //Проблемы здоровья и экология. - 2018. - №1 (55). - С. 8-15.

7. Щербаков Д. В. Изучение качества жизни пациентов с болезнями системы кровообращения на этапе реабилитации //Современные проблемы науки и образования. -2015. - №4. - С. 330-330.

8. Barth J. Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis /J. Barth, M. Schumacher, C. Herrmann-Lingen //Psychosomatic medicine. -2004. - V. 66, №6. - Pp. 802-813.

9. Behlouli H. Identifying relative cut-off scores with neural networks for interpretation of the Minnesota Living with Heart Failure questionnaire //Engineering in Medicine and Biology Society, 2009. EMBC 2009. Annual International Conference of the IEEE.- IEEE,2009.-Pp. 6242-6246.

10. Bonaterra G. A. Novel systemic cardiovascular disease biomarkers /G. A. Bonaterra, S. Zugel, R. Kinscherf //Current molecular medicine. - 2010. - V. 10, №2. - Pp. 180-205.

11. Clark A. M. Socioeconomic status and cardiovascular disease: risks and implications for care //Nature Reviews Cardiology. - 2009. - V. 6, №11. - Pp. 712.

12. Cohen S. Psychological stress and disease /S. Cohen, D. Janicki-Deverts, G. E. Miller // Jama. - 2007. - V. 298, №14. - Pp. 1685-1687.

13. Colotto M. Impact of depression syndrome in the management of cardiovascular risk factors in primary prevention: State of the art // La Clinica terapeutica. - 2010. - V. 161, №3. -Pp. e105-10.

14. Conroy R. M. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project //European heart journal. - 2003. - V. 24, №11. - Pp. 987-1003.

15. Danesh J. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease //New England Journal of Medicine. - 2004. - V. 350, №14. -Pp. 1387-1397.

16. Deloukas P. Large-scale association analysis identifies new risk loci for coronary artery disease //Nature genetics. - 2013. - V. 45, № 1. - Pp. 25.

17. Dong J. Y. Depression and risk of stroke: a meta-analysis of prospective studies // Stroke. - 2012. - V. 43, №1. - Pp. 32-37.

18. Dyussenova L. Associations between depression, anxiety and medication adherence among patients with arterial hypertension: Comparison between persons exposed and nonexposed to radiation from the Semipalatinsk Nuclear Test Site //Journal of environmental radioactivity. - 2018. - V. 195. - Pp. 33-39.

19. Elderon L. Depression and cardiovascular disease /L. Elderon, M. A. Whooley //Progress in cardiovascular diseases. - 2013. - V. 55, №6. - Pp. 511-523.

20. Expert Panel on Detection E. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) //Jama. - 2001. - V. 285, №19. - Pp. 2486.

21. Folsom A. R. Classical and novel biomarkers for cardiovascular risk prediction in the United States //Journal of epidemiology. - 2013. - V. 23, №3. - Pp. 158-162.

22. Haaf P. Quality of life as predictor for the development of cardiac ischemia in high-risk asymptomatic diabetic patients //Journal of Nuclear Cardiology. - 2017. - V. 24, №3. - Pp. 772782.

23. Goldston K. Depression and coronary heart disease: a review of the epidemiological evidence, explanatory mechanisms and management approaches /K. Goldston, A. J. Baillie //Clinical psychology review. - 2008. - V. 28, №2. - Pp. 288-306.

24. Grundy S. M. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition //Circulation. - 2004. - V. 109, №3. - Pp. 433-438.

25. Hamer M. Psychological distress as a risk factor for cardiovascular events: pathophysiological and behavioral mechanisms /M. Hamer, G. J. Molloy, E. Stamatakis //Journal of the American College of Cardiology. - 2008. - V. 52, №25. -Pp. 2156-2162.

26. Hare D. L. Depression and cardiovascular disease: a clinical review //European heart journal. - 2013. - V. 35, №21. - Pp. 1365-1372.

27. Huang C. Q. Chronic diseases and risk for depression in old age: a meta-analysis of published literature //Ageing research reviews. -2010. - V. 9, №2. - Pp. 131-141.

28. Jackson C. A. Depression and risk of stroke in midaged women: a prospective longitudinal study /C. A. Jackson, G. D. Mishra //Stroke. - 2013. - V. 44, №6. - Pp. 1555-1560.

29. Jensen M. K. Novel metabolic biomarkers of cardiovascular disease //Nature Reviews Endocrinology. - 2014. - V. 10, №11. - Pp. 659.

30. Jiang W. Prognostic value of anxiety and depression in patients with chronic heart failure //Circulation. - 2004. - V. 110, №22. - Pp. 3452-3456.

31. Kroenke K. The patient health questionnaire somatic, anxiety, and depressive symptom scales: a systematic review //General hospital psychiatry. - 2010. - V. 32, №4. - Pp. 345-359.

32. Lim S. S. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 //The lancet. -2012. - V. 380, №9859. - Pp. 2224-2260.

33. Lozano R. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 //The lancet. - 2012. - V. 380, №9859. - Pp. 2095-2128.

34. McManus D. Screening for depression in patients with coronary heart disease (data from the Heart and Soul Study) /D. McManus, S. S. Pipkin, M. A. Whooley //The American journal of cardiology. - 2005. - V. 96. - №8. - Pp. 10761081.

35. Meng L. Depression increases the risk of hypertension incidence: a meta-analysis of prospective cohort studies //Journal of hypertension. - 2012. - V. 30, №5. - Р. 842-851.

36. Michal M. Association of hypertension with depression in the community: results from the Gutenberg Health Study //Journal of hypertension. - 2013. - V. 31, №5. - Pp. 893-899.

37. Minnesota Living with Heart Failure Questionnaire / qol.thoracic.org URL: http:// qol.thoracic.org/sections/instruments/ko/pages/ mlwhfq.html (дата обращения: 24.10.2018).

38. Nakamura S. Prognostic value of depression, anxiety, and anger in hospitalized cardiovascular disease patients for predicting adverse cardiac outcomes //The American journal of cardiology.- 2013. - V. 111, №10. - Pp. 1432-1436.

39. Rahimi K. Cardiovascular disease and multimorbidity: A call for interdisciplinary research and personalized cardiovascular care /K. Rahimi, C. S. P. Lam, S. Steinhubl //PLoS Med. -2018. - V. 15 (3). - Pp. e1002545. https:// doi.org/10.1371/journal.pmed.1002545.

40. Ruo B. Depressive symptoms and health -related quality of life: the Heart and Soul Study //Jama. - 2003. - V. 290, №2. - Pp. 215221.

41. Schunkert H. Genetics of myocardial infarction: a progress report /H. Schunkert, J. Erdmann, N. J. Samani //European heart journal. - 2010. - V. 31, №8. - Pp. 918-925.

42. Singh V. Cardiac biomarkers - the old and the new: a review //Coronary artery disease. - 2010. - V. 21, №4. - Pp. 244-256.

43. Smith S. C. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute //Journal of the American College of Cardiology. - 2006. - V. 47, №10. - Pp. 21302139.

44. Spielberger C. D. Measuring the experience, expression, and control of anger /C. D. Spielberger, E. C. Reheiser, S. J. Sydeman // Issues in comprehensive pediatric nursing. -1995. - V. 18, №3. - Pp. 207-232.

45. Tully P. J. Generalized anxiety disorder prevalence and comorbidity with depression in coronary heart disease: a meta-analysis /P. J. Tully, S. M. Cosh //Journal of health psychology. - 2013. - V. 18, №12. - Pp. 1601-1616.

46. Tully P. J. Depression, anxiety, and cardiac morbidity outcomes after coronary artery bypass surgery: a contemporary and practical review /P. J. Tully, R. A. Baker //Journal of geriatric cardiology: JgC. - 2012.- V. 9,№2. - Pp. 197.

47. Wagner K. D. Presidential Address: Depression Awareness and Screening in Children and Adolescents //Journal of the American Academy of Child & Adolescent Psychiatry. - 2018. - V. 57, №1. - Pp. 6-7.

48. Webster R. A. Quality of Life in a mixed ethnic population after myocardial infarction // European Journal of Person Centered Healthcare. - 2017. - V. 5, №3. - Pp. 295-299.

49. Yano Y. Racial differences in associations of blood pressure components in young adulthood with incident cardiovascular disease by middle age: Coronary Artery Risk Development in Young Adults (CARDIA) Study //JAMA cardiology. - 2017. - V. 2, №4. - Pp. 381-389.

50. Zigmond A. S. The hospital anxiety and depression scale / A. S. Zigmond, R. P. Snaith // Acta psychiatrica scandinavica. - 1983. - V. 67, № 6. - Pp. 361-370.